AxoGen, Inc. (AXGN) Financials

AXGN Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 289.5 million 44.7 million
Dec. 31, 2025 221.7 million 92.8 million
Sept. 30, 2025 216.4 million 95.6 million
June 30, 2025 205.5 million 93.2 million

AXGN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -1.2 million 6.8 million
Dec. 31, 2025 1.8 million 16.6 million
Sept. 30, 2025 1.4 million 5.4 million
June 30, 2025 7.0 million 5.2 million

AXGN Net Income

No data available :(

AXGN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 82.7 million 18.5 million 20.6 million
Dec. 31, 2025 35.5 million 16.9 million 19.2 million
Sept. 30, 2025 35.8 million 48.2 million 19.8 million
June 30, 2025 35.9 million 47.9 million 20.3 million

AXGN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 51.6 million
Dec. 31, 2025 46.9 million
Sept. 30, 2025 45.9 million
June 30, 2025 45.6 million

AXGN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 2.8 million 7.5 million 41.5 million 28.6 million
Dec. 31, 2025 1.2 million 12.4 million 41.8 million 27.2 million
Sept. 30, 2025 1.9 million 7.6 million 36.5 million 25.7 million
June 30, 2025 722000 6.9 million 33.5 million 23.8 million

AXGN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 61.5 million 15.3 million
Dec. 31, 2025 59.9 million 15.5 million
Sept. 30, 2025 60.1 million 14.1 million
June 30, 2025 56.7 million 14.6 million

AXGN

Price: $43.74

52 week price:
9.22
45.83

Payout Ratio Range:
-1747.81%
59.60%

Earnings Per Share: -0.64 USD

Exchange: NCM

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 233500

Ebitda: -1.4 million

Market Capitalization: 2.3 billion

Links: